Amphastar Pharma (AMPH) Tops Q3 EPS by 11c

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.14, $0.11 better than the analyst estimate of $0.03. Revenue for the quarter came in at $64.2 million versus the consensus estimate of $65.12 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist